Cedars-Sinai Medical Center127 S San Vicente Blvd, Fl 7Los Angeles, CA 90048
Overview of Dr. Chan
Dr. Jason Chan is an oncology specialist based in New York, NY, with a subspecialty in sarcoma. He completed his medical degree at the University of California San Diego School of Medicine in 2014. Dr. Chan underwent residency training in Internal Medicine at Washington University/B-JH/SLCH Consortium from 2014 to 2016, followed by a fellowship in Hematology and Medical Oncology at Memorial Sloan Kettering Cancer Center from 2016 to 2020. He is currently an instructor and clinical fellow at Memorial Sloan Kettering Cancer Center. His research has been published in reputable journals such as Clinical Cancer Research, Cell, and Cancer Research Communications, with several of his works being frequently cited by other researchers in the field.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2016 - 2020
Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 2014 - 2016
University of California San Diego School of MedicineClass of 2014, MD
Certifications & Licensure
NJ State Medical License 2020 - 2027
NY State Medical License 2016 - 2027
MO State Medical License 2014 - 2016
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
ABIMMedical Oncology
Publications & Presentations
PubMed
- Integrated stress response couples mitochondrial fitness with lineage reprogramming to drive cancer evolution.Shiqi Diao, Jia Yi Zou, Shuo Wang, Jason E Chan, Roderik M Kortlever
Nature Cell Biology. 2026-07-01 - Phase 2 study of palbociclib plus retifanlimab in patients with advanced dedifferentiated liposarcoma.Evan Rosenbaum, Kenneth Seier, Rodrigo Gularte-Mérida, Evan Seffar, Mark A Dickson
Journal for Immunotherapy of Cancer. 2026-05-04 - Association of Circulating T Cell and Tumor Microenvironment Profiles with Immune Checkpoint Blockade Outcomes in Sarcoma.Evan Rosenbaum, Fiona Ehrich, Mohammad Yosofvand, Martina Bradic, Jasme Lee
Clinical Cancer Research. 2026-05-01
Press Mentions
Small Number of ‘Highly Plastic’ Cancer Cells Drive Disease Progression and Treatment ResistanceApril 8th, 2026- "Highly Plastic" Tumor Cells Drive Cancer ProgressionApril 8th, 2026
Grant Support
- Determining the role and function of a high plasticity cell state in lung adenocarcinomaSLOAN-KETTERING INST CAN RESEARCH2022–2027
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
